223 related articles for article (PubMed ID: 18989165)
1. Transient myeloproliferative disorder in neonates with and without Down syndrome: a tale of 2 syndromes.
Apollonsky N; Shende A; Ouansafi I; Brody J; Atlas M; Aygun B
J Pediatr Hematol Oncol; 2008 Nov; 30(11):860-4. PubMed ID: 18989165
[TBL] [Abstract][Full Text] [Related]
2. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
D'Angelo G; Merlo P
Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
[TBL] [Abstract][Full Text] [Related]
3. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.
Cushing T; Clericuzio CL; Wilson CS; Taub JW; Ge Y; Reichard KK; Winter SS
J Pediatr; 2006 May; 148(5):687-9. PubMed ID: 16737888
[TBL] [Abstract][Full Text] [Related]
4. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
Brink DS
Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
[TBL] [Abstract][Full Text] [Related]
5. Congenital transient myeloproliferative disorder progressing to acute myeloid leukemia in Down's syndrome: a case report.
Prabhu PD; V G; Niveditha SR; Gayathri BR; Keshavamurthy SR
Indian J Pathol Microbiol; 2004 Jan; 47(1):48-50. PubMed ID: 15471129
[TBL] [Abstract][Full Text] [Related]
6. Transient abnormal myelopoiesis of infancy associated with trisomy 21.
Homans AC; Verissimo AM; Vlacha V
Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):392-9. PubMed ID: 8214361
[TBL] [Abstract][Full Text] [Related]
7. Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome.
Kanegane H; Watanabe S; Nomura K; Xu G; Ito E; Miyawaki T
Int J Hematol; 2007 Oct; 86(3):250-2. PubMed ID: 17988992
[TBL] [Abstract][Full Text] [Related]
8. [Biventricular hypertrophic non-obstructive cardiomyopathy as a symptom of transient myeloproliferative disorder in a newborn with Down syndrome].
Wacker A; Scheel-Walter HG; Neunhoeffer F
Z Geburtshilfe Neonatol; 2009 Apr; 213(2):64-6. PubMed ID: 19319796
[TBL] [Abstract][Full Text] [Related]
9. WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder.
Hasle H; Lund B; Nyvold CG; Hokland P; Østergaard M
Leuk Res; 2006 May; 30(5):543-6. PubMed ID: 16242775
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
11. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for early death in transient myeloproliferative disorder without phenotypic features of Down syndrome: a case report and literature review.
Kawase K; Azuma E; Ohshita H; Tanaka T; Hanada Y; Sasaki T; Sugimoto M; Togawa T; Kouwaki M; Ito T; Hirayama M; Koyama N
J Pediatr Hematol Oncol; 2012 Aug; 34(6):475-9. PubMed ID: 22510770
[TBL] [Abstract][Full Text] [Related]
13. Transient myeloproliferative disorder and GATA1 mutation in neonates with and without Down syndrome.
Tsai MH; Hou JW; Yang CP; Yang PH; Chu SM; Hsu JF; Chiang MC; Huang HR
Indian J Pediatr; 2011 Jul; 78(7):826-32. PubMed ID: 21287369
[TBL] [Abstract][Full Text] [Related]
14. Analysis of GATA1 mutations and leukemogenesis in newborns with Down syndrome.
Queiroz LB; Lima BD; Mazzeu JF; Camargo R; Córdoba MS; Q Magalhães I; Martins-de-Sá C; Ferrari I
Genet Mol Res; 2013 Oct; 12(4):4630-8. PubMed ID: 24222239
[TBL] [Abstract][Full Text] [Related]
15. Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
Alford KA; Reinhardt K; Garnett C; Norton A; Böhmer K; von Neuhoff C; Kolenova A; Marchi E; Klusmann JH; Roberts I; Hasle H; Reinhardt D; Vyas P;
Blood; 2011 Aug; 118(8):2222-38. PubMed ID: 21715302
[TBL] [Abstract][Full Text] [Related]
16. Neonatal vesiculopustular eruption associated with transient myeloproliferative disorder: report of four cases.
Narvaez-Rosales V; de-Ocariz MS; Carrasco-Daza D; Ramirez-Davila B; Orozco-Covarrubias L; Duran-McKinster C; Palacios-Lopez C
Int J Dermatol; 2013 Oct; 52(10):1202-9. PubMed ID: 23046498
[TBL] [Abstract][Full Text] [Related]
17. Acute nonlymphocytic leukemia after transient myeloproliferative disorder in a patient with Down syndrome.
Barnett PL; Clark AC; Garson OM
Med Pediatr Oncol; 1990; 18(5):347-53. PubMed ID: 2142749
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory cytokinemia associated with transient myeloproliferative disorder in down syndrome.
Shimada A; Maruyama K; Shitara T; Kato M; Cho K; Kobayashi T; Fujiu T; Tsuchida Y; Nishida A; Hayashi Y; Minakami H; Kozawa K; Kimura H
Biol Neonate; 2004; 85(3):167-72. PubMed ID: 14671434
[TBL] [Abstract][Full Text] [Related]
19. Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.
Roy A; Roberts I; Norton A; Vyas P
Br J Haematol; 2009 Oct; 147(1):3-12. PubMed ID: 19594743
[TBL] [Abstract][Full Text] [Related]
20. Hydrops fetalis in a neonate with down syndrome, transient myeloproliferative disorder and hepatic fibrosis.
Anuk D; Tarcan A; Alioglu B; Avci Z; Haberal N; Ozyurek E; Ozbek N
Fetal Pediatr Pathol; 2007; 26(5-6):223-8. PubMed ID: 18363154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
